178 related articles for article (PubMed ID: 7616246)
1. Effect of nerve growth factor in ethylcholine mustard aziridinium (AF64A)-treated rats: sensitization of cholinergic enzyme activity in the septohippocampal pathway.
Willson CA; Hanin I
J Neurochem; 1995 Aug; 65(2):856-62. PubMed ID: 7616246
[TBL] [Abstract][Full Text] [Related]
2. Effects of AF64A on gene expression of choline acetyltransferase (ChAT) in the septo-hippocampal pathway and striatum in vivo.
Fan QI; Hanin I
Neurochem Res; 1999 Jan; 24(1):15-24. PubMed ID: 9973232
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor induced stimulation of septal choline acetyltransferase activity in ethylcholine mustard aziridinium treated rats.
Willson CA; Hanin I
Neurosci Lett; 1997 Jul; 229(3):149-52. PubMed ID: 9237480
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent effect of AF64A on cholinergic activity in the septo-hippocampal pathway of the rat brain: decreased responsiveness in aged rats.
El Tamer A; Wülfert E; Hanin I
Neurosci Lett; 1996 Jan; 203(2):123-6. PubMed ID: 8834109
[TBL] [Abstract][Full Text] [Related]
5. Long-term exposure to high levels of corticosterone aggravates AF64A-induced cholinergic hypofunction in rat hippocampus in vivo.
Amoroso D; Kindel G; Wülfert E; Hanin I
Brain Res; 1994 Oct; 661(1-2):9-18. PubMed ID: 7530584
[TBL] [Abstract][Full Text] [Related]
6. Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor L-deprenyl.
Ricci A; Mancini M; Strocchi P; Bongrani S; Bronzetti E
Drugs Exp Clin Res; 1992; 18(5):163-71. PubMed ID: 1490432
[TBL] [Abstract][Full Text] [Related]
7. Reversible cholinergic changes induced by AF64A in rat hippocampus and possible septal compensatory effect.
el Tamer A; Corey J; Wülfert E; Hanin I
Neuropharmacology; 1992 Apr; 31(4):397-402. PubMed ID: 1522957
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight glycosaminoglycan C3 attenuates AF64A-stimulated, low-affinity nerve growth factor receptor-immunoreactive axonal varicosities in the rat septum.
Dudas B; Rose M; Cornelli U; Hanin I
Brain Res; 2005 Feb; 1033(1):34-40. PubMed ID: 15680337
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and neuroanatomical consequences of a unilateral intraventricular infusion of AF64A and limitations on the neuroprotective effects of nimodipine.
Maier DL; Isaacson RL
Brain Res; 1994 Jun; 648(2):281-90. PubMed ID: 7922542
[TBL] [Abstract][Full Text] [Related]
10. Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64A.
Emerich DF; Walsh TJ
Brain Res; 1990 Sep; 527(2):299-307. PubMed ID: 2253037
[TBL] [Abstract][Full Text] [Related]
11. Serotonergic lesion of median raphe nucleus alters nerve growth factor content and vulnerability of cholinergic septohippocampal neurons in rat.
Hellweg R; Thomas H; Arnswald A; von Richthofen S; Kay S; Fink H; Morgenstern R; Hörtnagl H
Brain Res; 2001 Jul; 907(1-2):100-8. PubMed ID: 11430890
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic deficit induced by ethylcholine aziridinium (AF64A) transiently affects somatostatin and neuropeptide Y levels in rat brain.
Hörtnagl H; Sperk G; Sobal G; Maas D
J Neurochem; 1990 May; 54(5):1608-13. PubMed ID: 1969935
[TBL] [Abstract][Full Text] [Related]
13. Septohippocampal adaptive GABAergic responses by AF64A treatment.
Ayala-Grosso CA; Urbina-Paez R
J Neurosci Res; 1999 Jan; 55(2):178-86. PubMed ID: 9972820
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic deficit induced by ethylcholine aziridinium (AF64A) in rat hippocampus: effect on glutamatergic systems.
Hörtnagl H; Berger ML; Reither H; Hornykiewicz O
Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):213-9. PubMed ID: 1682822
[TBL] [Abstract][Full Text] [Related]
15. Effects of ethylcholine mustard azirinium ion (AF64A) on the choline acetyltransferase and nitric oxide synthase activities in mesopontine cholinergic neurons of the rat.
Rodríguez M; Mantolán-Sarmiento B; González-Hernández T
Neuroscience; 1998 Feb; 82(3):853-66. PubMed ID: 9483541
[TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices.
Leventer S; McKeag D; Clancy M; Wulfert E; Hanin I
Neuropharmacology; 1985 May; 24(5):453-9. PubMed ID: 3839570
[TBL] [Abstract][Full Text] [Related]
17. Moderate lesion of the rat cholinergic septohippocampal pathway increases hippocampal nerve growth factor synthesis: evidence for long-term compensatory changes?
Hellweg R; Humpel C; Löwe A; Hörtnagl H
Brain Res Mol Brain Res; 1997 Apr; 45(1):177-81. PubMed ID: 9105689
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of high affinity choline transport attenuates both cholinergic and non-cholinergic effects of ethylcholine aziridinium (AF64A).
Potter PE; Tedford CE; Kindel G; Hanin I
Brain Res; 1989 May; 487(2):238-44. PubMed ID: 2525061
[TBL] [Abstract][Full Text] [Related]
19. Time course of ethylcholine aziridinium ion (AF64A)-induced cholinotoxicity in vivo.
Leventer SM; Wulfert E; Hanin I
Neuropharmacology; 1987 Apr; 26(4):361-5. PubMed ID: 3587537
[TBL] [Abstract][Full Text] [Related]
20. The use of the rat iris as a model system to evaluate the effect of the cholinotoxin, AF64A, in vivo.
Willson CA; Luthman J; Hoffer B; Hanin I
J Neurosci Methods; 1995 Jan; 56(1):49-55. PubMed ID: 7715246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
